---
layout: post
title: "Request for Comments on Additional Modifications to the 301 Action To Address COVID-19: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation"
date: 2026-02-05 19:09:07 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-06285
original_published: 2020-03-25 00:00:00 +0000
significance: 8.00
---

# Request for Comments on Additional Modifications to the 301 Action To Address COVID-19: China's Acts, Policies, and Practices Related to Technology Transfer, Intellectual Property, and Innovation

**Published:** February 05, 2026 19:09 UTC
**Source:** Federal Register
**Original Published:** March 25, 2020 00:00 UTC
**Document Number:** 2020-06285

## Summary

In prior notices, the U.S. Trade Representative has modified the action in the Section 301 investigation of China's acts, policies, and practices related to technology transfer, intellectual property, and innovation by removing additional duties from medical-care products needed to address the COVID-19 outbreak. In light of ongoing developments, the Office of the U.S. Trade Representative (USTR) is requesting public comments on possible further modifications to remove duties from additional medical-care products.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/03/25/2020-06285/request-for-comments-on-additional-modifications-to-the-301-action-to-address-covid-19-chinas-acts)
- API: https://www.federalregister.gov/api/v1/documents/2020-06285

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
